This inventor holds 4 USPTO granted patents and 9 published patent applications. Top assignee: Curium US LLC. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Jarno Jalomäki: Innovator in Pharmaceutical Composition
Introduction
Jarno Jalomäki is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance patient safety and treatment efficacy.
Latest Patents
Jarno Jalomäki holds a patent for a pharmaceutical composition titled "LU lutetium-PSMA IandT composition and dosimetry, kit, method of making, and method of using thereof." This patent describes a composition that includes Lu-PSMA I&T and outlines methods for its administration. The administration of this composition is designed to result in a low absorbed radiation dose per gram of tissue in a human patient's body, including critical organs such as the kidneys, gastrointestinal tract, liver, and salivary glands. He has 1 patent to his name.
Career Highlights
Jarno Jalomäki is currently employed at Curium US LLC, where he continues to work on advancements in pharmaceutical technologies. His expertise in the field has positioned him as a valuable asset to his company and the broader medical community.
Collaborations
Some of his coworkers include Salla Seppänen and Amanda Donovan, who contribute to the innovative environment at Curium US LLC.
Conclusion
Jarno Jalomäki's work in developing safer pharmaceutical compositions exemplifies the impact of innovation in healthcare. His contributions are paving the way for improved patient outcomes and advancing the field of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile